PRELUDE CAPITAL MANAGEMENT, LLC

Position in MDXG — Mimedx Group, Inc.

CIK 1387508 NEW YORK, NY

Position in MDXG

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$828,670

+$566,744 QoQ

Shares Held

215,239

+524.5% QoQ

Ownership

0.148%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#46

of 224 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names. MDXG ranks #7 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	58,590	$7,776,650
2	TECH	BIO-TECHNE Corp	91,696	$6,478,322
3	PGEN	Precigen, Inc.	882,267	$5,028,921
4	ROIV	Roivant Sciences Ltd.	113,104	$4,002,750
5	RVMD	Revolution Medicines, Inc.	10,997	$2,059,518
6	QURE	uniQure N.V.	32,229	$1,484,467
7	MDXG	Mimedx Group, Inc. This page	215,239	$828,670
8	CGON	CG Oncology, Inc.	10,811	$768,121

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$828,670	215,239	+524.5%	Shares	Other	2026-08-14
2025-03-31	$261,926	34,464	-85.1%	Shares	Other	2025-05-15
2024-12-31	$2,218,785	230,643	-41.9%	Shares	Other	2025-02-14
2024-09-30	$2,345,820	396,924	-5.8%	Shares	Other	2024-11-14
2024-06-30	$2,920,378	421,411	+35.5%	Shares	Other	2024-08-14
2024-03-31	$2,394,476	310,971	+5.5%	Shares	Other	2024-05-15
2023-12-31	$2,584,817	294,734	-18.7%	Shares	Other	2024-02-14
2023-09-30	$2,643,835	362,666	+2822.1%	Shares	Other	2023-11-14
2023-03-31	$42,321	12,411	-12.0%	Shares	Other	2023-06-01
2021-03-31	$145,250	14,102	+5.7%	Shares	Other	2021-05-17
2020-12-31	$121,190	13,347	—	Shares	Other	2021-02-16
No filing history on record for this holder in this stock.